<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02677571</url>
  </required_header>
  <id_info>
    <org_study_id>20995/2014ps</org_study_id>
    <nct_id>NCT02677571</nct_id>
  </id_info>
  <brief_title>PVB vs PECS Block in Breast Surgery</brief_title>
  <acronym>PVBvsPECS</acronym>
  <official_title>Thoracic Paravertebral Block Versus Pectoral Nerves Block (Modified PECS) Block in Breast Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituti Ospitalieri di Cremona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituti Ospitalieri di Cremona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose to compare paravertebral thoracic block (PVB) and pectorals nerves block as analgesic
      option for major breast surgery.

      102 patients undergoing reconstruction breast surgery will be randomized into two groups:
      Group PVB (n=51) will receive US guided paravertebral thoracic block (between T2-T6)
      performed with 30ml of 0.25% levobupivacaine before general anesthesia (TCI-TIVA) induction.

      Morphine patient control analgesia (PCA) with loading dose i.v. titrated by the PACU nurse if
      pain &gt; 5/10 at rest Group PECS (n=51) will receive US guided pectorals nerves block performed
      with 30ml of 0.25% levobupivacaine before general anesthesia (TCI-TIVA) induction.

      Morphine PCA with loading dose i.v. titrated by the post-anesthesia care unit (PACU) nurse if
      pain &gt; 5/10 at rest

      Primary Outcome Measures:

      Morphine consumption (mg) (Time Frame: 24 hours) in two Groups

      Secondary Outcome Measures:

      Pain at rest and during movement quantified as Numerical Rating Scores (0-10) during the
      first 24 hours postoperatively.

      Eventual side effects such as nausea/vomiting. Time necessary to perform the procedure. Pain
      during procedure execution quantified as Numerical Rating Scores (0-10) Hypnotic and opioids
      intraoperative consumption to ensure general anesthesia with Bispectral Index between 40 and
      60.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PCA morphine consumption in the two groups within the first 24 postoperative hours</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scores for pain at rest and during movement</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea/vomiting incidence</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of performance</measure>
    <time_frame>During procedure execution</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Propofol consumption in intraoperative period</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Propofol consumption in intraoperative period to maintain total intravenous general anesthesia (BIS target 40-60). Propofol consumption in mg/kg/h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioids (remifentanyl) consumption in intraoperative period</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Opioids (remifentanyl) consumption in intraoperative period to maintain total intravenous general anesthesia (systolic blood pression target: reduction of 20% from base line value). Remifentanyl in mcg/kg/h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scores during procedure execution</measure>
    <time_frame>During procedure execution</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Reconstruction Breast Surgery</condition>
  <arm_group>
    <arm_group_label>PVB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>51 patients receiving US guided homolateral paravertebral thoracic block with 30ml of 0.25% levobupivacaine, before general anesthesia (TCI-TIVA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PECS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>51 patients receiving US guided pectorals nerve block with 30ml of 0.25% levobupivacaine, before general anesthesia (TCI-TIVA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Paravertebral Thoracic block</intervention_name>
    <arm_group_label>PVB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pectorals nerve block</intervention_name>
    <arm_group_label>PECS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0.25%</intervention_name>
    <arm_group_label>PVB</arm_group_label>
    <arm_group_label>PECS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <arm_group_label>PVB</arm_group_label>
    <arm_group_label>PECS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt; 18 years

          -  ASA score I - II - III

          -  undergoing elective reconstruction breast surgery

          -  signed informed consent

        Exclusion Criteria:

          -  chronic therapy with opioids/ antidepressants

          -  urgent/emergent surgery

          -  postoperative transfer to the intensive care unit

          -  known allergy to any drug medication

          -  local skin infection

          -  epilepsy

          -  alcohol or drug abuse
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giorgio F Danelli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Istituti Ospedalieri di Cremona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliera Istituti Ospitalieri di Cremona</name>
      <address>
        <city>Cremona</city>
        <state>CR</state>
        <zip>26100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2016</study_first_submitted>
  <study_first_submitted_qc>February 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2016</study_first_posted>
  <last_update_submitted>February 2, 2017</last_update_submitted>
  <last_update_submitted_qc>February 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituti Ospitalieri di Cremona</investigator_affiliation>
    <investigator_full_name>Giorgio Danelli</investigator_full_name>
    <investigator_title>Chief of the Anaesthesia Department, Istituti Ospitalieri, Cremon</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

